¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"wide field ocular"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • dark field microscope
    ¾Ï½Ã¾ßÇö¹Ì°æ
  • dark field microscopy
    ¾Ï½Ã¾ßÇö¹Ì°æ°Ë»ç(¹ý)
  • dark-field illumination
    ¾Ï½Ã¾ßÁ¶¸í
  • diplopia field
    º¹½Ã½Ã¾ß, °ãº¸Àӽþß
  • electric field
    Àü±âÀå
  • electromagnetic field
    ÀüÀÚ±âÀå
  • field
    1. ºÐ¾ß, ¿µ¿ª, ¹üÀ§ 2. ºÎÀ§ 3. ½Ã¾ß 4. Àü±âÀå
  • field block
    ºÎÀ§Â÷´Ü
  • field defect
    ½Ã¾ß°á¼Õ
  • field inhomogeneity
    ÀÚÀåºÒ±ÕÁú¼º
  • field survey
    ÇöÁöÁ¶»ç
  • field test
    ½ÇÁõ°Ë»ç
  • field uniformity
    Á¶»ç¿µ¿ª±ÕÀϼº, Á¶»ç¸é±ÕÀϼº
  • fringe field
    ÁÖº¯¿µ¿ª
  • geometric field distortion artifact
    ±âÇÏÇÐÀûÀÚÀå¿Ö°îÀΰø¹°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • complex receptive field
    º¹ÇÕ¼ö¿ë¾ß
  • comprehensive field irradiation
    ±¤¹üÀ§Á¶»ç
  • confrontation field test
    ´ë¸é½Ã¾ß°Ë»ç
  • congruous field defect
    ÀÏÄ¡½Ã¾ß°áÇÔ
  • constant field equation
    Á¤ÀüÀ广Á¤½Ä
  • dark field microscope
    ¾Ï½Ã¾ßÇö¹Ì°æ
  • dark field microscopy
    ¾Ï½Ã¾ßÇö¹Ì°æ°Ë»ç
  • dark-field illumination
    ¾Ï½Ã¾ßÁ¶¸í
  • diplopia field
    º¹½Ã½Ã¾ß, °ãº¸Àӽþß
  • field defect
    ½Ã¾ß°á¼Õ
  • incongruous field defect
    ºÒÀÏÄ¡½Ã¾ß°á¼Õ
  • visual field defect
    ½Ã¾ß°á¼Õ
  • electric field
    Àü±âÀå
  • magnetic field effect
    ÀÚ±âÀåÈ¿°ú
  • pulsed-field gel electrophoresis
    °£Ç濵¿ª°ÖÀü±âÀ̵¿
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • ocular larva migrans
  • ocular lens
    ´ë¾È(ÓßäÑ)·»Áî.
  • ocular lens
    ´ë¾È(ÓßäÑ)·»Áî
  • ocular media
    ¾È±¸¸Åü
  • ocular melanosis
    ´« ÈæÇÇÁõ
  • ocular micrometer
    Á¢¾È¸¶ÀÌÅ©·Î¹ÌÅÍ
  • ocular migraine =ophthalmicum, ³ª migraena ocularis
    ¾È¼ºÆíµÎÅë(äÑàõø¶Ôé÷Ô).
  • ocular motility
    ¾È±¸¿îµ¿
  • ocular movement
    ¾È±¸¿îµ¿(äÑϹê¡ÔÑ).
  • ocular muscle palasy
    ¾È±Ù¸¶ºñ.
  • ocular muscle paralysis
    ¾È±Ù¸¶ºñ
  • ocular muscles
    ¾È±¸±ÙÀ°
  • ocular myoclonus
  • ocular myopathy
    ¾È±Ùº´Áõ
  • ocular nystagmus
    ½Ã°¢¼º¾ÈÁø, ½Ã°¢¼º´«¶³¸²
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • middle lung field
    Á߯ó¾ß
  • near field
    ±Ù¿ª
  • radio-frequency field
    °íÁÖÆÄÀÚÀå
  • rectangular field of view (FOV)
    Á÷»ç°¢Çü½Ã¾ß
  • slice selection gradient field
    ÀýÆí¼±Åðæ»çÀå
  • sound field
    À½¿ª
  • static field
    Á¤ÀÚÀå
  • static field inhomogeneity
    Á¤ÀÚÀåºÒ±ÕÁú
  • static magnetic field
    Á¤ÀÚÀå
  • super high field MR scanner
    ÃʰíÀÚÀåMR½ºÄ³³Ê, ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra high field MR scanner
    ÃʰíÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • ultra low field MR scanner
    ÃÊÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
  • upper lung field
    »óÆó±¸¿ª, »óÆó¾ß
  • vertical field magnet
    ¼öÁ÷ÀÚÀåÀÚ¼®
  • visual field defect
    ½Ã¾ß°á¼Õ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
AROA autosomal recessive ocular albinism
ASOD anterior segmental ocular dysgenesis
COACH cerebellar vermis hypoplasia/aplasia-oligophrenia-congenital ataxia-ocular colobomata-hepatic fibros...
COD cause of death; cerebro-ocular dysplasia; chemical oxygen demand; codeine; condition on discharge
COD-MD cerebro-ocular dysplasia-muscular dystrophy [syndrome]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
OPG Ocular Pneumoplethysmography
OPA Ocular Pulse Amplitude
OTR Ocular Tilt Reaction
OA1 Ocular albinism type 1
OCP Ocular cicatricial pemphigoid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dark-field microscope
    ¾Ï½Ã¾ß Çö¹Ì°æ
    ¾Ï½Ã¾ß Á¶¸í¹ý¿¡ ÀÇÇØ º¸ÅëÀÇ Çö¹Ì°æÀ¸·Î´Â º¸ÀÌÁö ¾Ê´Â ¹Ì¼¼ÇÑ ÀÔÀÚ¸¦ º¼ ¼ö ÀÖ´Â Çö¹Ì°æ. ÇÑ¿Ü Çö¹Ì°æÀ» ¸»Çϴµ¥, ¾Ï½Ã¾ß Á¶¸í°ú ±× Áý±¤ ·»Á »ç¿ëÇϹǷΠÀÌ¿Í °°ÀÌ ºÒ¸®±âµµ ÇÑ´Ù.
  • depository field
    ÷°¡ ¾ß
  • electromagnetic field
    ÀüÀÚÀå
    1. Àü±âÀå°ú ÀÚ±âÀåÀ» ÅëÆ²¾î ÁöĪÇÏ´Â ¸». 2. Àü±âÀå°ú ÀÚ±âÀåÀÌ ¼­·Î ¿¬°üµÇ¾î °°ÀÌ ³ªÅ¸³¯ ¶§ À̸£´Â ¸».
  • equivalent field
    µî°¡ Á¶»ç ¿µ¿ª
  • eye field
    ½Ã¾ß
  • far field
    ¿ø°Å¸® ±¸¿ª
  • field
    ±¸¿ª, ¾ß, ¿µ¿ª
    1. ÀÛ¿ë ¿µ¿ª ¶Ç´Â Àå¼Ò³ª °ø°£. 2. Áö½Ä, ¿¬±¸, Á÷¾÷¿¡ À־ÀÇ Àü¹® ºÐ¾ß. 3. ¹ß»ýÇп¡ ÀÖ¾î º¯µ¿ ¿äÀÎÀÇ ¹üÀ§ ³»¿¡¼­ ºÐÈ­ÇÏ´Â ¿µ¿ª.
  • field cancerization
    ±¸¿ª ¾ÏÈ­
  • field echo
    ÀÚÀå ¿¡ÄÚ
  • field inhomogeneity
    ÀÚÀå ºÒ±ÕÀÏ, ÀÚÀå ºÒ±ÕÀϼº
  • field profile
    ÀÚÀå Ãø¸é »ó
  • field strength
    ÀÚÀå ¼¼±â, ÀÚÀå·Â
  • field survey
    ÇöÁö Á¶»ç
  • fringe field
    ÁÖº¯ ¾ß
  • fringe magnetic field strength
    ÁÖº¯ ÀÚÀå ¼¼±â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
ocular nystagmus The pendular or, rarely, jerky nystagmus seen in severely reduced vision.
Synonym: amaurotic nystagmus.
(05 Mar 2000)
ocular onchocerciasis Ocular complications, such as keratitis, iridocyclitis, or retrobulbar neuritis, caused by the microfilariae of Onchocerca volvulus.
Synonym: river blindness.
(05 Mar 2000)
ocular paralysis Paralysis of extraocular and intraocular muscles.
(05 Mar 2000)
ocular pemphigoid A conjunctivitis with transient small vesicles, a viscid ropy discharge, symblepharon, xerosis, and trichiasis, eventually becoming bilateral.
(05 Mar 2000)
ocular physiology Functions and activities of the eye as a whole or of any of its parts.
(12 Dec 1998)
ocular prosthesis An artificial eye or implant.
(05 Mar 2000)
ocular rigidity The resistance offered by the eyeball to a change in intraocular volume; manifested as a change in intraocular pressure.
(05 Mar 2000)
ocular scoliosis Scoliosis supposed to be due to head tilting, caused by ophthalmological dysfunction.
(05 Mar 2000)
ocular sparganosis Infestation of the orbits with the sparganum of Spirometra mansoni; characterised by redness and oedema of the eyelids, lacrimation, and blepharoptosis; acquired by application of infected raw frog flesh against the eye as a poultice.
(05 Mar 2000)
ocular tension Resistance of the tunics of the eye to deformation; it can be estimated digitally or measured by means of a tonometer.
(05 Mar 2000)
ocular torticollis Torticollis incident to paralysis of an extraocular muscle, especially an oblique muscle.
(05 Mar 2000)
ocular vertigo Dizziness attributed to refractive errors or imbalance of the extrinsic muscles.
(05 Mar 2000)
ocular vesicle In the embryo, one of the paired evaginations from the ventrolateral walls of the forebrain from which the sensory and pigment layers of the retina develop.
Synonym: vesicula ophthalmica, ocular vesicle, optic vesicle.
(05 Mar 2000)
onchocerciasis, ocular Filarial infection of the eyes transmitted from person to person by bites of onchocerca volvulus-infected black flies. The microfilariae of onchocerca are thus deposited beneath the skin. They migrate through various tissues including the eye. Those persons infected have impaired vision and up to 20% are blind. The incidence of eye lesions has been reported to be as high as 30% in central america and parts of africa.
(12 Dec 1998)
toxoplasmosis, ocular Infection caused by the protozoan parasite toxoplasma in which there is extensive connective tissue proliferation, the retina surrounding the lesions remains normal, and the ocular media remain clear. Chorioretinitis may be associated with all forms of toxoplasmosis, but is usually a late sequel of congenital toxoplasmosis. The severe ocular lesions in infants may lead to blindness.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • field grads
    ¿µ°ü±Þ
  • field gray
    ¾Ïȸ»ö;±ºº¹;µ¶ÀϺ´
  • field gun
    ¾ßÆ÷
  • field hand
    ³óÀå ³ëµ¿ÀÚ
  • field hockey
    À°»ó ÇÏŰ
  • field hospital
    ¾ßÀü º´¿ø
  • field house
    °æ±âÀåÀÇ ºÎ¼Ó °Ç¹°;½Ç³»°æ±âÀå
  • field ice
    ºù¿ø;¾ßºù
  • field intensity
    ÀåÀÇ ¼¼±â;Àü°èÀÇ °­µµ
  • field ion microscope
    À̿ ¹æ»ç Çö¹Ì°æ;Àü°è À̿ Çö¹Ì°æ
  • field jacket
    ¾ßÀü¿ë ÀçŶ
  • field judge
    ÇÊµå ½ÉÆÇ
  • field kitchen
    ¾ß¿Ü(¾ßÀü)Ãë»çÀå
  • field lacrosse
    ¶óÅ©·Î½º
  • field lark
    =MEADOWLARK
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á